资源描述
Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,Click to edit Master title style,Your company slogan,Gastric MALT Lymphoma,Keith Deng,Roche,Gastric MALT Lymphoma,Self,-,Introduction,1,MALT Lymphoma Overview,2,Pathology&Diagnosis,3,T,reatment,4,Roche,MabThera,Roche,MabThera,Gastric MALT Lymphoma,Self,-,Introduction,1,MALT Lymphoma Overview,2,Pathology&Diagnosis,3,T,reatment,4,MALT lymphoma,Overview,胃MALT淋巴瘤,diagnosis of,gastric lymphoma is difficult at an earlier stage due to its nonspecific,symptoms,and,endoscopic findings,肿瘤发病部位,非胃MALT淋巴瘤,甲状腺、小肠、唾液腺、眼附属器(结膜、泪腺、眼眶)、呼吸道(肺、咽喉、支气管)、皮肤、乳腺、泌尿生殖道(膀胱、前列腺、输尿管、肾脏),甚至硬脑膜等多个器,*,Marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue(MALT),50%,and diffuse large B-cell lymphoma are the most common histologic types of gastric lymphoma,Roche,MabThera,Gastric MALT Lymphoma,Overview,胃MALT淋巴瘤约占50%左右,以成人多见,胃是MALT淋巴瘤是最常累及的部位,结外淋巴瘤 E,xtrodonal lymphoma,PGL accounts for 30%-40%of all extranodal lymphomas,Roche,MabThera,one of the most common chronic infections,more than half of the worlds population is infected,H.pylori infection is the primary pathologic cause of development of low-grade,mucosa-associated lymphoid tissue(MALT)lymphoma of the stomach,International guidelines strongly recommend bacterial eradication in all gastric MALT lymphoma patient,early stages low-grade MALT lymphoma can be cured by H.pylori eradication in 60%-80%of cases,胃MALT淋巴瘤与HP(Helicobacter pylori 幽门螺杆菌)感染相关,Roche,MabThera,胃MALT淋巴瘤与HP感染相关的证据,临床流行病学资料,Wotherspoon等:110 例(92%),Doglioni等:H.Pylori,胃MALT淋巴瘤,欧阳钦等:78 例(87.2%),H.Pylori,相关胃炎中发现与淋巴瘤相同序列的单克隆性B细胞,Roche,MabThera,Gastric MALT Lymphoma,Self,-,Introduction,1,MALT Lymphoma Overview,2,Pathology&Diagnosis,3,T,reatment,4,Roche,MabThera,选材,病理,免疫组化,原位杂交,PCR,从,DNA,水平确定单克隆性,精确地在亚临床、亚病理阶段检出恶性克隆,(,阳性率,85%),mRNA,水平检测,Ig,轻链限制性,区别肿瘤性或反应性浆细胞,鉴别炎症与早期肿瘤,(75%),检测活检组织中免疫球蛋白,(Ig),轻链限制性,(,简单、快捷,阳性率,20%-50%),资深病理医师阅片,共同磋商,重复取材、多处深取,粘膜切除(,EMR,),胃MALT淋巴瘤的阶梯式诊断流程,RT-PCR,检测,t(11;18)(q21;q21),易位,可作为,Hp,治疗效果的标记,有此易位者抗,Hp,效果不好,(适用于诊断不清的病例,主要用于区分,GML,与,RHL,),Gastric MALT Lymphoma,Self,-,Introduction,1,MALT Lymphoma Overview,2,Pathology&Diagnosis,3,Treatment,4,Roche,MabThera,胃MALT淋巴瘤分期,不同分期系统比较,Roche,MabThera,根除HP治疗,许多试验已经评价了抗生素治疗胃MALT淋巴瘤的有效性,大约2/3局限性胃MALT淋巴瘤患者在根除HP治疗后达到肿瘤完全缓解(CR),Stolte回顾总结了744例早期胃MALT淋巴瘤,抗Hp后71%可以治愈。,日本报告完全与部分缓解率为83%,但每年约5%病例复发。,个别报告根除Hp甚至使胃外如唾液腺、十二指肠、小肠、直肠的淋巴瘤消退,Roche,MabThera,根除HP治疗,Wundisch等对E期胃MALT淋巴瘤进行抗生素根治H pylori治疗(n=120),116人(97%)经过一线的抗生素治疗HP得到根除,而其余4人经过二线抗生素治疗后HP也得到了根治.,80%的患者(96/120)经过抗HP治疗后获得CR,出现CR在应用抗生素治疗后1-28 mo,61%(59/96)能在前3 mo就获得CR,临床CR的患者5 a无复发率平均为71%(68%-81%),Roche,MabThera,放疗,对于H pylori根治无效或者不适用抗H pylori治疗的患者,首选放疗,有效的照射野应包括全胃以及胃周淋巴结;如果食管下端或者十二指肠也受到侵犯,那么放射野应该相应的扩大.,治疗剂量通常为30 Gy左右,Sloan-Kettering癌症纪念医院:51名HP阴性的胃MALT淋巴瘤患者,中位放疗剂量为30 Gy,5 a无病生存率、总生存率和疾病特异生存率分别为89%,83%和100%,Park等:6例HP阴性/抗HP治疗无效的期和期的胃MALT淋巴瘤患者进行单一放射治疗.中位照射剂量是30.6 Gy,照射胃及胃周淋巴结4 wk时间,结果显示所有患者治疗均有效,6 a无瘤生存率100%.,推荐治疗方案,Roche,MabThera,NCCN指南中胃MALT淋巴瘤治疗,Roche,MabThera,NCCN指南中胃MALT淋巴瘤治疗,放疗/化疗3个月后再分期和内镜随访,内镜随访,Roche,MabThera,NCCN指南中胃MALT淋巴瘤治疗,内镜随访,Roche,MabThera,NCCN指南中胃MALT淋巴瘤治疗,Roche,MabThera,Roche,MabThera,TREATMENT OF GASTRIC MALT LYMPHOMA,Hoon Jai Chun,MD,PhD,AGAF,Professor,Series Editor,;,World J Gastroenterol 2014 March 21;20(11):2751-2759,Roche,MabThera,TREATMENT OF GASTRIC MALT LYMPHOMA,研究设计,HP阴性和HP根除后持续疾病,的,胃MALT,淋巴瘤,(CD20,+,),I,E,IV,期 107例,24.9-83.9,岁,非,随,机,分,组,Aliment Pharmacol Ther.2014 Mar;39(6):619-28.doi:10.1111/apt.12635.Epub 2014,Jan 27,Aim:long term outcomes,中位随访期4.9年,Alkylating alone,chlorambucil,(,苯丁酰氮芥),36,cyclophosphide,(环磷酰胺),12,Rituximab alone,29,Combination R+C,30,Roche,MabThera,TREATMENT OF GASTRIC MALT LYMPHOMA,Aliment Pharmacol Ther.2014 Mar;39(6):619-28.doi:10.1111/apt.12635.Epub 2014 Jan 27,Roche,MabThera,TREATMENT OF GASTRIC MALT LYMPHOMA,Aliment Pharmacol Ther.2014 Mar;39(6):619-28.doi:10.1111/apt.12635.Epub 2014,Jan 27,Roche,MabThera,IELSG-19,III期临床研究,首要研究终点:无事件生存,次要研究终点:总生存、缓解率,median follow-up 5 years,Chlorambucil,daily,6mg/,m,(2),6weeks,有效和稳定的 连续14day/28day,4 cycle,(n=,113,),Ritumab+chlorambucil,days 1,8,15,22,56,84,112,140,共,8,周期,(n=,114,),对局部治疗无效或不适合局部治疗的且未经化疗的,MALT Lymphoma,Gastric accounts 37%,CD20+MALT Lymphoma,18,etranodel,疗效评估,J Clin Oncol.2013 Feb 10;31(5):565-72.doi:10.1200/JCO.2011.40.6272.Epub 2013 Jan 7,Roche,MabThera,IELSG-19,III期临床研究,chlorambucil,chlorambucil,+R(加,美罗华,),OR 87%,OS 89%,CR 65%,EFS 50%,OR 90%,OS 89%,CR 78%,EFS 68%,J Clin Oncol.2013 Feb 10;31(5):565-72.doi:10.1200/JCO.2011.40.6272.Epub 2013 Jan 7,5-year,Roche,MabThera,Thank you!,Roche,MabThera,
展开阅读全文